The global veterinary dermatology market, valued at US$18.59 billion in 2024, is forecasted to grow at a robust CAGR of 8.5%, reaching US$20.11 ...

The global veterinary dermatology market, valued at US$18.59 billion in 2024, is forecasted to grow at a robust CAGR of 8.5%, reaching US$20.11 billion in 2025 and an impressive US$30.31 billion by ...

The global veterinary dermatology market, valued at US$18.59 billion in 2024, is forecasted to grow at a robust CAGR of 8.5%, ...

We recently compiled a list of the 12 Best Low Price Pharma Stocks To Invest In Right Now. In this article, we are going to ...

Private Advisor Group LLC increased its position in Elanco Animal Health Incorporated (NYSE:ELAN – Free Report) by 6.3% in the 4th quarter, according to its most recent 13F filing with the SEC. The ...

In a big win for House Speaker Mike Johnson, House Republicans got their budget plan through the chamber on a 217-215 vote.

Elanco Animal Health Incorporated has entered into an agreement with South Dakota-based Medgene to leverage the company's ...

Elanco Animal Health Incorporated (NYSE: ELAN) today announced it has entered into an agreement with South Dakota-based ...

Elanco Animal Health Incorporated (NYSE:ELAN – Get Free Report) shares reached a new 52-week low during mid-day trading on Tuesday after the company announced weaker than expected quarterly earnings.

A novel parasite protection therapy from Elanco Animal Health received FDA approval in October 2024, and was recently made available on the market with a launch at the 2025 Veterinary Meeting & Expo ...

Elanco Animal Health announced the establishment of an agreement with Medgene, a South Dakota-based biotechnology company, to utilize its advanced vaccine platform technology (baculovirus derived ...

Elanco's Q4 revenue reached $1.02 billion, topping estimates, but EPS missed forecasts. 2025 guidance lags consensus as currency headwinds pose a $110 million challenge.